A group of primers for detecting fⅷ/fⅸ gene mutation in hemophilia patients and its application
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- 陕西医大血友病研究院
- Publication Date
- 2021-08-24
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to PCR amplification primers in genetic engineering, especially a set of primers for detecting FⅧ / FIX gene mutations in hemophilia patients, and using the primers to classify the etiology of hemophilia, and targeted according to the classification results Treatment for hemophilia. Background technique
[0002] Hemophilia is a group of genetic diseases characterized by three highs (high bleeding rate, high mortality rate, and high disability rate) [1~2] . In the past 20 years, due to the development of molecular biology technology, it has been found that the cause of hemophilia is mainly FⅧ / FⅨ gene mutation [1] , In addition, it was found that a small number of patients had no genetic family history, but the gene mutation of the patient [3] , another 1.5 / 100,000 patients are acquired hemophilia A (Acguired hemophilia A, AHA) [4~5] , but there is still a lack of unified etiological classification criteria for hemophilia, which b...